A complete application in a minute
Tailored resume and cover letter, ready to send.
Jazz Pharmaceuticals seeks an Associate Director of Epidemiology to lead strategic epidemiology across oncology programs and provide cross-functional support to neurology. You will design non-interventional NHS and ECAs, oversee PMRs/PMCs, and contribute to regulatory submissions and portfolio forecasting.
The role requires rare-disease epidemiology expertise, strong data strategy, and ability to collaborate with Clinical Development, Regulatory Affairs, Medical Affairs, and GVHEOR in a global,
Jazz Pharmaceuticals is a global biopharma company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases — often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines, including leading therapies for sleep disorders and epilepsy, and a growing portfolio of cancer treatments. Our patient-focused and science-driven approach powers pioneering research and development advancements across our robust pipeline of innovative therapeutics in oncology and neuroscience. Jazz is headquartered in Dublin, Ireland with research and development laboratories, manufacturing facilities and employees in multiple countries committed to serving patients worldwide. Please visit www.jazzpharmaceuticals.com for more information.
The Associate Director (AD) of Epidemiology will provide strategic epidemiological leadership and operational execution across Jazz Pharmaceuticals' Global Research & Development (R&D) organization. This role will primarily focus on oncology programs (including rare hematology and solid tumors), while providing agile, cross-functional support to neurology development programs as needed.
The AD will be responsible for the scientific design, leadership, and operational management of non-interventional pharmacoepidemiology studies, including Natural History of Disease studies (NHS), external control arms (ECAs), post-marketing requirements/commitments (PMR/PMC), and disease registries. Additionally, the role will spearhead the identification, synthesis, and communication of relevant epidemiological evidence to support clinical development, orphan drug designations, regulatory submissions (e.g., Risk Management Plans, Periodic Benefit-Risk Evaluation Reports), commercial forecasting, and health authority interactions globally.
Given the focus on niche indications and unmet medical needs, demonstrated expertise in rare disease epidemiology is required. The AD will report to the Senior Director of Epidemiology.
Education: Advanced degree (PhD, ScD, DrPH, or MS/MPH) in Epidemiology, Pharmacoepidemiology, Health Services Research, or a closely related quantitative public health discipline.
Industry Experience: Minimum of 4+ years (for PhD) or 6+ years (for Master's) of relevant experience in the pharmaceutical/biotechnology industry, an academic research center, or an epidemiology/RWE-focused CRO.
Rare Disease Expertise: Proven, hands‑on experience designing and executing epidemiological studies in rare diseases, including navigating low‑prevalence data limitations, case‑finding algorithms, and natural history study designs.
Oncology Experience: Demonstrated track record of leading epidemiological research in oncology (solid tumors, hematologic malignancies, or rare cancer indications).
Study Design & Methodologies: Proven expertise in non-interventional study designs, including retrospective/prospective cohorts, disease registries, and synthetic/external control arms (ECAs) using real‑world data.
Secondary Data Acumen: Direct experience working with complex longitudinal healthcare databases (e.g., EMR networks such as Flatiron, US Oncology, or Tempus; claims databases such as IQVIA, Optum, MarketScan; and disease‑specific registries).
Project Management & Matrix Leadership: Demonstrated ability to independently lead cross‑functional study teams, manage external vendor performance and budgets, and balance multiple priorities across fast‑paced development programs.
Communication: Exceptional written and verbal communication skills in English, with proven ability to translate complex epidemiological methods to non-technical stakeholders and regulatory reviewers.
Work Arrangement & Travel: Ability to work effectively in a hybrid/remote matrix environment, with availability to travel approximately 10% as needed.
Jazz Pharmaceuticals is an equal opportunity/affirmative action employer and all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, disability status, protected veteran status, or any characteristic protected by law.
Jazz Pharmaceuticals, Inc. is committed to fair and equitable compensation practices and we strive to provide employees with total compensation packages that are market competitive. For this role, the full and complete base pay range is: $156,000.00 - $234,000.00
Individual compensation paid within this range will depend on many factors, including qualifications, skills, relevant experience, job knowledge, and other pertinent factors. The goal is to ensure fair and competitive compensation aligned with the candidate's expertise and contributions, within the established pay framework and our Total Compensation philosophy. Internal equity considerations will also influence individual base pay decisions. This range will be reviewed on a regular basis.
The successful candidate will also be eligible to participate in various benefits offerings, including, but not limited to, medical, dental and vision insurance, 401k retirement savings plan, and flexible paid vacation.